The company gained 4.4 billion euros in sales in 2010, with its Hospital Care and Aesculap division representing the largest contributors to growth. The company was able to expand its workforce and increase spending on research and development last year while also bolstering worldwide production capacity.
The company announced last month that it will be investing 50 million euros into expanding its manufacturing and logistics facilities in Glandorf, Germany.
Read the Zenopa release about B. Braun.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
